Independence Bank of Kentucky Raises Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Independence Bank of Kentucky lifted its position in Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 73.2% during the fourth quarter, HoldingsChannel reports. The institutional investor owned 866 shares of the medical equipment provider’s stock after purchasing an additional 366 shares during the period. Independence Bank of Kentucky’s holdings in Intuitive Surgical were worth $292,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently modified their holdings of ISRG. DAVENPORT & Co LLC raised its stake in shares of Intuitive Surgical by 13.3% during the fourth quarter. DAVENPORT & Co LLC now owns 5,624 shares of the medical equipment provider’s stock valued at $1,897,000 after acquiring an additional 661 shares during the last quarter. Regent Peak Wealth Advisors LLC bought a new position in Intuitive Surgical in the 4th quarter worth about $232,000. Stonegate Investment Group LLC increased its position in shares of Intuitive Surgical by 8.6% during the fourth quarter. Stonegate Investment Group LLC now owns 2,605 shares of the medical equipment provider’s stock valued at $879,000 after acquiring an additional 206 shares in the last quarter. TIAA Trust National Association raised its stake in shares of Intuitive Surgical by 5.6% in the fourth quarter. TIAA Trust National Association now owns 2,156 shares of the medical equipment provider’s stock worth $727,000 after purchasing an additional 115 shares during the last quarter. Finally, Pinnacle Financial Partners Inc lifted its stake in Intuitive Surgical by 5.5% during the 4th quarter. Pinnacle Financial Partners Inc now owns 19,543 shares of the medical equipment provider’s stock valued at $6,593,000 after acquiring an additional 1,012 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Down 3.2 %

Shares of ISRG stock opened at $382.36 on Wednesday. The firm’s 50 day moving average price is $386.82 and its two-hundred day moving average price is $335.66. The stock has a market cap of $135.53 billion, a price-to-earnings ratio of 76.02, a price-to-earnings-growth ratio of 6.13 and a beta of 1.36. Intuitive Surgical, Inc. has a fifty-two week low of $250.01 and a fifty-two week high of $403.76.

Intuitive Surgical (NASDAQ:ISRGGet Free Report) last released its quarterly earnings results on Tuesday, January 23rd. The medical equipment provider reported $1.60 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.48 by $0.12. The firm had revenue of $1.93 billion for the quarter, compared to the consensus estimate of $1.89 billion. Intuitive Surgical had a net margin of 25.24% and a return on equity of 13.11%. The firm’s quarterly revenue was up 16.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.91 EPS. On average, equities analysts forecast that Intuitive Surgical, Inc. will post 4.93 EPS for the current fiscal year.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Mark Brosius sold 196 shares of the stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now directly owns 1,842 shares in the company, valued at approximately $736,800. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other Intuitive Surgical news, VP Marshall Mohr sold 108,790 shares of the stock in a transaction on Wednesday, February 28th. The shares were sold at an average price of $385.08, for a total transaction of $41,892,853.20. Following the sale, the vice president now directly owns 26,877 shares of the company’s stock, valued at $10,349,795.16. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Mark Brosius sold 196 shares of the firm’s stock in a transaction dated Tuesday, March 5th. The stock was sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the transaction, the senior vice president now owns 1,842 shares in the company, valued at $736,800. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock worth $95,927,097 in the last 90 days. 0.80% of the stock is owned by corporate insiders.

Analyst Ratings Changes

A number of analysts recently commented on the company. Mizuho upped their price objective on Intuitive Surgical from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Thursday, January 25th. Wells Fargo & Company raised their target price on shares of Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research note on Friday, January 19th. Stifel Nicolaus reaffirmed a “buy” rating and issued a $420.00 price target on shares of Intuitive Surgical in a report on Friday, March 15th. Barclays raised their price target on shares of Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research note on Thursday, January 25th. Finally, Royal Bank of Canada boosted their price objective on shares of Intuitive Surgical from $400.00 to $432.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 24th. Five equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $371.60.

Get Our Latest Research Report on Intuitive Surgical

Intuitive Surgical Company Profile

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Read More

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report).

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.